Modulation of hyperglycemia and dyslipidemia in experimental type 2 diabetes by gallic acid and p-coumaric acid: The role of adipocytokines and PPARγ

被引:78
作者
Abdel-Moneim, Adel [1 ]
Abd El-Twab, Sanaa M. [1 ]
Yousef, Ahmed I. [1 ]
Reheim, Eman S. Abdel [1 ]
Ashour, Mohamed B. [1 ]
机构
[1] Beni Suef Univ, Mol Physiol Div, Dept Zool, Fac Sci, Salah Salem St, Bani Suwayf 62511, Egypt
关键词
Gallic acid; p-Coumaric acid; Type 2 diabetic rats; TNF-alpha; Adiponectin; PPAR gamma; INDUCED INSULIN-RESISTANCE; PROINFLAMMATORY CYTOKINES; PEROXISOME PROLIFERATOR; GLUCOSE-UPTAKE; ADIPONECTIN; RATS; STREPTOZOTOCIN; DIFFERENTIATION; ANTIOXIDANT; ACTIVATION;
D O I
10.1016/j.biopha.2018.06.096
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
There are many indications that confirm the vital role of adipocytokines and PPAR gamma in diabetics. Hence, the current investigation aimed to study the modulatory effects of gallic acid and p-coumaric acid on adipocytokines secretion and PPAR gamma mRNA expression in type 2 diabetic rats. After induction of type 2 diabetes, diabetic rats were orally treated with 20 mg/kg body mass gallic acid and 40 mg/kg body mass p-coumaric acid for six weeks. Among treatment diabetic rats, glucose and glycosylated hemoglobin levels significantly declined in diabetic rats, while insulin level and body weight significantly increased as compared to control group. Gallic acid and p-coumaric acid markedly decreased the level of TNF-alpha and increased the levels of PPAR gamma mRNA and adiponectin. In addition, the tested agents improved markedly lipid profile parameters, cardiovascular indices 1 and 2 and anti-atherogenic index. In conclusion, gallic acid and p-coumaric acid exhibited marked antidiabetic action that could be mediated via modulation of TNF-alpha and adipocytokines secretions as well as upregulation of PPAR gamma mRNA expression.
引用
收藏
页码:1091 / 1097
页数:7
相关论文
共 58 条
[31]   Insulin-secretagogue, antihyperlipidemic and other protective effects of gallic acid isolated from Terminalia bellerica Roxb. in streptozotocin-induced diabetic rats [J].
Latha, R. Cecily Rosemary ;
Daisy, P. .
CHEMICO-BIOLOGICAL INTERACTIONS, 2011, 189 (1-2) :112-118
[32]   Sorting out the roles of PPARα in energy metabolism and vascular horneostasis [J].
Lefebvre, P ;
Chinetti, G ;
Fruchart, JC ;
Staels, B .
JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (03) :571-580
[33]   An extract of Lagerstroemia speciosa L. has insulin-like glucose uptake-stimulatory and adipocyte differentiation-inhibitory activities in 3T3-L1 cells [J].
Liu, F ;
Kim, JK ;
Li, YH ;
Liu, XQ ;
Li, J ;
Chen, XH .
JOURNAL OF NUTRITION, 2001, 131 (09) :2242-2247
[34]   Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method [J].
Livak, KJ ;
Schmittgen, TD .
METHODS, 2001, 25 (04) :402-408
[35]  
Malloy M J, 2001, Adv Intern Med, V47, P111
[36]   Experimental NIDDM - Development of a new model in adult rats administered streptozotocin and nicotinamide [J].
Masiello, P ;
Broca, C ;
Gross, R ;
Roye, M ;
Manteghetti, M ;
Hillaire-Buys, D ;
Novelli, M ;
Ribes, G .
DIABETES, 1998, 47 (02) :224-229
[37]   Trends in the prevalence and incidence of diabetes in the UK: 1996-2005 [J].
Masso Gonzalez, E. L. ;
Johansson, S. ;
Wallander, M-A ;
Garcia Rodriguez, L. A. .
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2009, 63 (04) :332-336
[38]  
Mohamed H.M., 2016, CAN J PHYSL PHARM, V94, P1
[39]  
Moneim AA, 2016, INT J BIOASSAYS, V5, P4641, DOI DOI 10.21746/ijbio.2016.06.0011
[40]  
Nobert W. T., 1995, CLIN GUIDE LAB TESTS, V3rd